News
A new study published in the journal of BMC Nephrology showed that hemodialysis patients with end-stage renal disease (ESRD) ...
Atrial fibrillation is relatively common in patients with chronic aortic regurgitation and is associated with an elevated ...
23h
HealthDay on MSNA-Fib Linked to Worse Outcomes for Patients With Heart Failure, MR Undergoing Valve RepairFor patients with heart failure and severe mitral regurgitation (MR) undergoing transcatheter edge-to-edge repair (M-TEER), ...
The data from 2019 to 2023 show rapid uptake of the drugs alongside wide patient- and practice-level variations.
Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could become a new treatment for people whose ...
Atrioventricular interval modulation is being studied for patients with uncontrolled hypertension. Could the new technology ...
AstraZeneca's Phase 3 trial showed baxdrostat lowered systolic blood pressure in treatment-resistant hypertension with a ...
AstraZeneca said on Monday its experimental drug baxdrostat significantly lowered blood pressure in a late-stage trial of ...
3d
News-Medical.Net on MSNAI-powered ECG model outperforms doctors in detecting hidden heart diseaseResearchers developed an AI-powered ECG model, EchoNext, that detects structural heart disease with high accuracy across ...
The readout is particularly welcome for AZ as baxdrostat (formerly CIN-107) showed mixed results in earlier hypertension ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results